In bladder cancer, SLC14A1+ CAFs produce WNT5A to confer stemness to bladder tumor cells, in turn tumor cells drive interferon production to enhance SLC14A1+ CAF differentiation 29. This evidence concerns the gene WNT5A and urinary bladder carcinoma.